。$四季教育(FEDU)$ $华富教育(WAFU)$查看全文
智通财经APP讯,先声药业(02096)发布公告,该公司与Kazia Therapeutics Limited(Kazia)合作的创新药SIM0395(Paxalisib)于2021年12月6日获得中国国家药品监督管理局签发的药物临床试验批准通知书,拟用于胶质母细胞瘤(GBM),包括新诊断和... 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-091813 Act: 34 Size: 313 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-084734 Act: 34 Size: 53 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-080410 Act: 34 Size: 50 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-064411 Act: 34 Size: 50 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-062094 Act: 34 Size: 59 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-021511 Act: 34 Size: 164 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-003636 Act: 34 Size: 49 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-21-000151 Act: 34 Size: 205 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-20-319484 Act: 34 Size: 36 KB 网页链接
$Kazia Therapeutics(KZIA)$ 6-K Report of foreign issuer [Rules 13a-16 and 15d-16] Accession Number: 0001193125-20-319491 Act: 34 Size: 37 KB 网页链接